To compare the efficacy and tolerability of adjunctive high frequency rTMS pluspregabalin over pregabalin alone in patients with CPSP: A randomized double-blind cross over trial in single-center tertiary care referral teaching hospital. - RTMS-CPSP

Professor Jayantee Kalita0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•Age more than 18 years, those fulfilling the diagnostic criteria of CPSP, pain intensity more than equal to 4 on a Visual analog scale (VAS, 0 to 10 with 0 indicating no pain and 10 the worst pain imaginable), those who will give the consent to participate in the study

•Age more than 70 years and less than 18 years, patients with less than 4 pain on VAS, epilepsy, pregnancy, metallic implant, pacemaker, painful peripheral neuropathy, complex regional pain syndrome, psychiatric and post-head injury pain disorders, bony defect of scalp, chronic renal or liver failure, heart failure, cancer, and those with a history of drug allergy will be excluded. The patients with dementia and aphasia, and those who are not willing to give consent will also be excluded.

发起方

Professor Jayantee Kalita